共 14 条
[1]
[Anonymous], 2022, Emergency Use Authorization
[2]
FDA, 2016, Non-inferiority clinical trials to establish effectiveness-FDA guidance for industry
[3]
FDA, 2022, FDA Announces Bebtelovimab is Not Currently Authorized in Any US Region | FDA
[4]
FDA, 2022, Frequently Asked Questions on the Emergency Use Authorization of Bebtelovimab for the Treatment of COVID-19
[5]
FDA, 2022, FDA Updates Sotrovimab Emergency Use Authorization
[6]
FDA, 2023, Coronavirus Treatment Acceleration Program (CTAP) Internet. Coronavirus (COVID-19) drugs
[7]
Food and Drug Administration (FDA), 2024, FDA REVISES LETT AUT
[8]
Food and Drug Administration (FDA), 2021, EMERGENCY USE AUTHOR